5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Authors
Keywords
5-FU resistance, Cancer stemness, Angiogenesis, DNA repair, MDR modulators, Combination therapy
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 137, Issue -, Pages 111285
Publisher
Elsevier BV
Online
2021-01-20
DOI
10.1016/j.biopha.2021.111285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
- (2020) Raquel B. Liszbinski et al. Materials
- A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer
- (2020) Michael J Pishvaian et al. CLINICAL CANCER RESEARCH
- lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer
- (2020) Peilong Li et al. Molecular Therapy-Nucleic Acids
- The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
- (2020) Plabon Kumar Das et al. Cells
- Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
- (2020) Jose J.G. Marin et al. Cancers
- Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation
- (2019) Anmada Nayak et al. CELLULAR ONCOLOGY
- Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancer
- (2019) Xiaoli Zhang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Therapeutic considerations of PARP in stem cell biology: Relevance in cancer and beyond
- (2019) M. Zeniou et al. BIOCHEMICAL PHARMACOLOGY
- New folate receptor targeted nano liposomes for delivery of 5-fluorouracil to cancer cells: Strong implication for enhanced potency and safety
- (2019) Somayeh Handali et al. LIFE SCIENCES
- Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential
- (2019) Elisabete Fernandes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse
- (2019) Chinmayee Sethy et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer
- (2019) Somayeh Handali et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
- (2019) Sona Vodenkova et al. PHARMACOLOGY & THERAPEUTICS
- Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry
- (2018) Jiangying Cao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
- (2018) N. O. Elander et al. BRITISH JOURNAL OF CANCER
- Nogo-B receptor promotes epithelial–mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway
- (2018) Donghua Wu et al. CANCER LETTERS
- DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo
- (2018) Hongzhi Du et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
- (2018) Ying Song et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells
- (2018) Junyu Cao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
- (2018) Xu Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia
- (2018) Manman Deng et al. Journal of Translational Medicine
- Involvement of Prokineticin 2–expressing Neutrophil Infiltration in 5-Fluorouracil–induced Aggravation of Breast Cancer Metastasis to Lung
- (2018) Soichiro Sasaki et al. MOLECULAR CANCER THERAPEUTICS
- KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells
- (2018) Guo-Jin Wu et al. MOLECULAR CARCINOGENESIS
- Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression
- (2018) Kazuaki Matsuoka et al. Oncotarget
- Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
- (2018) Karolina Tecza et al. Oncotarget
- A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo
- (2018) Dan-Dan Li et al. CELL PROLIFERATION
- Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy
- (2018) Somayeh Handali et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis
- (2018) Jun Hee Lee et al. JOURNAL OF PINEAL RESEARCH
- A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes
- (2018) Somayeh Handali et al. BIOMEDICINE & PHARMACOTHERAPY
- Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein
- (2018) Wen-ting He et al. Chinese Journal of Integrative Medicine
- The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
- (2018) Ryutaro Mori et al. Gastric Cancer
- Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
- (2018) Awad Jarrar et al. STEM CELLS
- Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
- (2017) Min Xu et al. EXPERIMENTAL CELL RESEARCH
- Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy
- (2017) Sakib Iqbal et al. Journal of Biomedical Nanotechnology
- Astragaloside IV downregulates the expression of MDR1 in Bel-7402/FU human hepatic cancer cells by inhibiting the JNK/c-Jun/AP-1 signaling pathway
- (2017) Pei-Pei Wang et al. Molecular Medicine Reports
- Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma
- (2017) Monica Bartucci et al. Targeted Oncology
- Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients
- (2017) Jun Chen et al. WIENER KLINISCHE WOCHENSCHRIFT
- Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer
- (2017) Hongsheng Tang et al. Oncotarget
- Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapy
- (2017) Natalia M. Leguisamo et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- dUTPase inhibition augments replication defects of 5-Fluorouracil
- (2017) Anna Hagenkort et al. Oncotarget
- miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2
- (2017) Ling Ye et al. Molecular Therapy-Nucleic Acids
- Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models
- (2017) Agnieszka Denslow et al. PLoS One
- Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent ofhMLH1status
- (2016) Satoshi Suzuki et al. CANCER BIOLOGY & THERAPY
- ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli
- (2016) Sumit Siddharth et al. DNA REPAIR
- Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent
- (2016) Yuqi Jiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent
- (2016) Nipaporn Ngernyuang et al. Materials Science & Engineering C-Materials for Biological Applications
- Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition
- (2016) Safeena Kulsum et al. MOLECULAR CARCINOGENESIS
- The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells
- (2016) Falu Yuan et al. MOLECULES
- E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy
- (2016) Violetta Sulzyc-Bielicka et al. PATHOLOGY & ONCOLOGY RESEARCH
- Reversal effect and mechanism of Ginkgo biloba exocarp extracts in multidrug resistance of mice S180 tumor cells
- (2016) Bi-Yuan Hu et al. Experimental and Therapeutic Medicine
- Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration
- (2016) Laura Patras et al. Oncology Letters
- Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
- (2016) Samuel Gonçalves-Ribeiro et al. Oncotarget
- FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
- (2016) Tao Xie et al. Oncotarget
- Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
- (2016) Karolina Tecza et al. Oncotarget
- Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein
- (2016) Chengyong Dong et al. Oncotarget
- Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
- (2016) Shusuke Toden et al. Oncotarget
- Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage
- (2016) Yan Yan et al. Oncotarget
- Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
- (2016) Matthieu Corvaisier et al. Oncotarget
- NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade
- (2015) Dipon Das et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
- (2015) Shusuke Toden et al. CARCINOGENESIS
- Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells
- (2015) TAKAAKI MIYAKE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias
- (2015) M. V. V. Falzacappa et al. MOLECULAR CANCER THERAPEUTICS
- 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype
- (2015) Tung-Cheng Chang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors
- (2015) Meriam Ayadi et al. Oncotarget
- Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
- (2015) Jhih-Ying Chi et al. Oncotarget
- Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma
- (2015) Hong Yang et al. Oncotarget
- 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
- (2015) Upadhyayula Sai Srinivas et al. Oncotarget
- 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
- (2015) Corti Denise et al. Oncotarget
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing
- (2015) Kalpesh Patel et al. Oncotarget
- HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
- (2015) Ganji Purnachandra Nagaraju et al. Oncotarget
- Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study
- (2014) M-C Etienne-Grimaldi et al. BRITISH JOURNAL OF CANCER
- 5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway
- (2014) Dipon Das et al. DNA REPAIR
- Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells
- (2014) Teng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent studies of 5-fluorouracil resistance in pancreatic cancer
- (2014) Wei-Bin Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition
- (2013) Kenji Sakogawa et al. CANCER SCIENCE
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- An integrated analysis of the association between Ts gene polymorphisms and clinical outcome in gastric and colorectal cancer patients treated with 5-FU-based regimens
- (2013) Ying-Chao Wang et al. MOLECULAR BIOLOGY REPORTS
- MSH3 Mismatch Repair Protein Regulates Sensitivity to Cytotoxic Drugs and a Histone Deacetylase Inhibitor in Human Colon Carcinoma Cells
- (2013) Jae Myung Park et al. PLoS One
- 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of Resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells
- (2013) Dipon Das WORLD JOURNAL OF GASTROENTEROLOGY
- Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
- (2013) Violetta Sulzyc-Bielicka et al. CELLULAR ONCOLOGY
- VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA
- (2012) L. K. Martin et al. ANNALS OF ONCOLOGY
- Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer
- (2012) J.A. van der Zee et al. EJSO
- Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells
- (2012) Ryutaro Mori et al. Gastric Cancer
- SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress
- (2012) Pratik Nagaria et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung−/−Msh2−/− mice
- (2012) Kristin Kemmerich et al. NUCLEIC ACIDS RESEARCH
- DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
- (2011) Moriya Iwaizumi et al. CANCER BIOLOGY & THERAPY
- Expression patterns of endothelin-1 and its receptors in colorectal cancer
- (2011) Paraskevi Liakou et al. JOURNAL OF SURGICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation
- (2011) Henrik Sahlin Pettersen et al. NUCLEIC ACIDS RESEARCH
- Identification of genes conferring resistance to 5-fluorouracil
- (2009) B. K. Yoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Participation of DNA repair in the response to 5-fluorouracil
- (2008) M. D. Wyatt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now